NCT02016183View on ClinicalTrials.gov

Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)

CompletedOBSERVATIONAL
Enrollment

3,222

Participants

Timeline

Start Date

April 1, 2009

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Hypertension
Interventions
DRUG

Candesartan cilexetil / hydrochlorothiazide

Candesartan cilexetil / hydrochlorothiazide combination tablets

Trial Locations (1)

Unknown

Tokyo

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY